#T2D is an active hashtag on Bluesky. In the last 30 days, 18 people shared 50 posts with it — around 2 a day. Activity is down 35% versus the previous week, peaking on Sep 2 with 4 posts.

Posts with #T2D

heather IS NOT SPAM‼️ pls 🔁📌 (away)

@k1llstreakz.bsky.social

3 months ago

COMMUNITY CARE REQUIRED! 🚨my friend is begging to live💔mem has #T2D, many comorbid conditions, lacks access to FOOD, medicine, med equip. & MORE ⚠️🚨 this is not in alignment with their survival. cash.me/$memwho venmo.com/u/memwho ko-fi.com/memwho #HelpSky💕💸 #MutualAid #FundSky #HelpFolksLive2026

a selfie of me, heather, a white woman with brown hair and brown eyes. i’m wearing a denim tegan and sara baseball cap, clear lenses, and a white n95 respirator mask. and striped tshirt. i’m looking to the side. i added text that says DON’T LOOK AWAY. ca$, venmo, kofi is memWho. paypal: xomemereytwod

Red grungy flyer with text that reads as follows: SHOW CARE for @memwho2. Over $1000 in NON-NEGOTIABLE expenses: vital medical monitors, groceries & supplies, 1/2 of July rent, and eye exam to renew ID. before the fifteenth. It's spent months reaching TOO FEW who chose to help. Utilities gone unmet all this time and recurring supporters limited, they've forced into $600 debt to cashapp with BP and glucose fatally high, OUTPRICED of a stabilizing diet. This is DETERIORATION. PLEASE find helpers. Keep 2 disabled Black people and 2 senior cats safe. linktr.ee/torqu111

1 29 52

Scott Soleimanpour

@soleimanpourlab.bsky.social

11 months ago

New from us! Had a question about mitophagy but were afraid to ask? 😂 Excited to review the latest advances in beta cell mitophagy research as a key adaptive response in all forms of diabetes in @cp-trendsendomet.bsky.social. We'd be honored if you have it a read! #T1D #T2D

Trends in Endocrinology and Metabolism @cp-trendsendomet.bsky.social

Online Now: Mitophagy in the adaptation to pancreatic β cell stress in diabetes #trends #endocrinology #metabolism

dlvr.it

1 9 27

Atanas G. Atanasov

@atanas-g-atanasov.bsky.social

over 1 year ago

💡 Having late breakfast decreases the raise of blood sugar after meal 🌐 #Diabetes #INPST #T2D #HealthyLifestyle #Health #Nutrition #Science www.sciencedirect.com/sci….

www.sciencedirect.com

Modifying the timing of breakfast improves postprandial glycaemia in people with type 2 diabetes: A randomised controlled trial

Investigate the effects of breakfast timing on postprandial glycaemia in adults with type 2 diabetes (T2D), and the impact of a 20-min walk after brea…

4 3 24

Daniel Drucker

@danieljdrucker.bsky.social

10 months ago

Giants in #diabetes science recognized with awards at the Levine-Riggs symposium. Congratulations to Dr. Kevan Herold @Yale and Dr. Alvin Powers @VanderbiltU Thank you for your innovation and dedication to rigorous translational diabetes science #T1D #T2D www.cityofhope.org/resear….

0 1 23

Irfan Lodhi

@lodhilab.bsky.social

about 1 year ago

Happy to share our new paper in @nature.com led by staff scientist Xuejing Liu. We report identification of a UCP1-independent pathway of brown fat thermogenesis involving ATP-consuming metabolism of BCFA in peroxisomes. #Obesity #T2D www.nature.com/articles/s41...

4 5 20

reeinspired - zepbound journey

@reeinspired.bsky.social

over 1 year ago

It’s my 4 month #Zepbound anniversary! #glp1 #mounjaro #t2d

4 0 20

Daniel Drucker

@danieljdrucker.bsky.social

over 1 year ago

A detailed P3 look at the leading small molecule oral GLP-1 RA orforglipron studied at a range of doses for moderate #T2D Good tolerability, solid efficacy on glucose and #weightloss no serious off target SAEs www.nejm.org/doi/full/10....

www.nejm.org

Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes | NEJM

Orforglipron is a small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist in clinical development for type 2 diabetes and weight management. Additional data on the efficacy and ...

0 7 18

heather IS NOT SPAM‼️ pls 🔁📌 (away)

@k1llstreakz.bsky.social

3 months ago

they’re begging to live💔 please help. mem has #T2D, many comorbid conditions, & irregular access to FOOD, medicine, and MORE ⚠️🚨 this is not in alignment with their survival. cash.me/$memwho venmo.com/u/memwho ko-fi.com/memwho #HelpSky💕💸 #MutualAid #FundSky #HelpFolksLive2026

please help food insecure: BP, glucose, A1C off the charts.
neglected in new marriage after mom died 2011. diabetes & adhd treatment was stopped metformin largest dose may not be more helpful than injectable's req. medicaid.
im ab to pay for a 2nd dose+new med with all i have from a request! $30.
there is a picture attached that is the results of my blood glucose test, which was 363 this was taken at the health clinic on june8

1 16 17

The Lancet Diabetes & Endocrinology

@thelancetendo.bsky.social

about 20 hours ago

#Intermittent #fasting, the practice of periodically fasting for up to 48 h, has surged in popularity over the past decade. An estimated 13% of adults in the USA practice intermittent fasting, making it the third most commonly practiced diet www.thelancet.com/journal…. #T2D #MedSky #EndoSky

www.thelancet.com

Intermittent fasting to treat diabetes: time to update clinical practice guidelines

Intermittent fasting is now the third most commonly practiced diet in the USA. Yet, despite more than 225 clinical trials—including nearly 40 in patients with diabetes or prediabetes—intermittent fast...

0 0 1

BeFab Hollie

@befabulous-hollie.bsky.social

almost 2 years ago

Today VS 1 year ago If this is "Ozempic Face" I'll take it!! #weightlossjourney #mounjarojourney #wellnessjourney #glp1 #GLP1Medications #mounjaro #weightloss #diabetes #type2diabetes #t2d

1 0 15

Daniel Drucker

@danieljdrucker.bsky.social

12 months ago

Inflammation is a key driver of the pathophysiology of cardiometabolic disorders #obesity #T2D and new metabolic medicines based on GLP-1 action exert their magic in part by reducing inflammation. A new review from Professor Donath summarizes the field www.sciencedirect.com/sci…?

www.sciencedirect.com

Obesity, diabetes, and inflammation: Pathophysiology and clinical implications

Obesity and its related disorders, including type 2 diabetes and liver, kidney, and cardiovascular diseases, are now recognized as chronic inflammator…

1 4 15

Daniel Drucker

@danieljdrucker.bsky.social

about 1 year ago

The new metabolic medicines #T2D #obesity and #inflammation www.cell.com/trends/endoc...

www.cell.com

Repurposing metabolic drugs as anti-inflammatory agents

Dysregulation of bodyweight systemic metabolism is intrinsically linked to an inflammatory phenotype, with each underpinning the other. Over the past decade, new classes of drug, such as glucagon-like...

0 3 15